Growing Pipeline of ADC Candidates for Various Cancer Indications is Driving the IndustryDublin, April 25, 2025 (GLOBE NEWSWIRE) -- The An ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that ...

Quasicrystals, exotic states of matter characterized by an ordered structure with non-repeating spatial patterns, have been the focus of numerous recent physics studies due to their unique ...

Antibody-drug conjugates have emerged as one of the most ... Analysing data from 2022, Beacon Intelligence found that the number of new ADCs entering the clinic had doubled compared to 2021.

Strategic investing beats market predictions. Read here for two stocks that offer reliable income, strong business models, ...

We recently published a list of 11 Oversold NASDAQ Stocks to Buy Right Now. In this article, we are going to take a look at ...

While simply explained here, ADCs are incredibly complex molecules which can be engineered in a multitude of ways to result in conjugates ... analysis should take a number of considerations ...

Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the New England Journal of Medicine (NEJM) has published a detailed analysis of the Phase III CENTERSTONE trial ...

We recently published a list of the 11 Cheap NASDAQ Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other cheap ...